以岭药业(002603.SZ)发布前三季度业绩，归母净利润10亿元，同比增长80.33%

Core Insights - The company reported a revenue of 5.868 billion yuan for the first three quarters of 2025, representing a year-on-year decline of 7.82% [1] - The net profit attributable to shareholders of the listed company reached 1 billion yuan, showing a significant year-on-year increase of 80.33% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 966 million yuan, reflecting a year-on-year growth of 90.53% [1]